Measure Instrument Development and Support (MIDS)

Telligen, a leading provider of health management solutions, was selected by the Centers for Medicare & Medicaid Services (CMS) as one of 31 organizations that will carry out $1.6 billion in projects related to healthcare quality measurement over the next decade. The Measure and Instrument Development and Support, or MIDS, will fund work related to improving the quality, outcomes, and efficiency of Medicare services over the next decade.

“This important win affords us the opportunity to continue working side-by-side with CMS on quality measurement projects that are setting the course for the future of healthcare delivery,” says Teresa Titus-Howard, Vice President of Federal Health Management.

Under MIDS, Telligen will help CMS develop and implement clinical quality measures; which are tools for tracking and measuring the quality of healthcare services. Clinical quality measures are used in CMS’ public reporting programs to:

  • Evaluate providers and facilities against recognized quality standards;
  • Direct financial awards or penalties to providers based on their ability to deliver quality services; and
  • Promote transparency and informed consumer choice via public reporting.

Telligen’s specialized expertise in clinical quality measures is increasingly vital as CMS tests new payment and delivery models, while moving toward a system that rewards value and quality over quantity.

“Our employee-owners’ passion for quality measurement is demonstrated by both our longevity in this space, and the direct relationship the work has with our mission to transform lives and economies by improving health,” says Lindsey Wisham, Director of Federal Health Management. “With our employee-owners’ continued support, the healthcare system will move closer toward meaningful measures that result in better, safer care for patients, increase cost transparency for consumers, and more accurate information for policymakers working on delivery system reform,” says Wisham.

Read the Full Press Release